Cornell University
Ithaca, New York, United States
Purpose
to develop rapid and reversible male contraceptive therapies by setting up a spermatogonial stem cell culture system that can be used to identify genes required for the first stage of sperm formation – meiotic division of the spermatogonial
Division
Global Health
Date
April 2017
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
31
Grantee location
Ithaca, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.